The trial will evaluate the efficacy of psilocybin in Short-lasting Unilateral Neuralgiform Headache Attacks (SUNHA). The data is expected in early 2022
The division will focus on products that are required during ophthalmic surgical procedures like cataracts and refractive surgeries among others
Packaged junk food which is a major component of unhealthy diets is responsible for more deaths worldwide than any other risk factor
The net proceeds from the issue will be utilised towards the purchase of machinery, modernising existing units and expansion of its R&D facilities
This clinical study demonstrated that the 14-day regimen of ImmunoSEB and ProbioSEB CSC3 resolved post-Covid-19 fatigue symptoms and improved patients' functional status and quality of life
Extension of hypericin orphan designation beyond cutaneous T-cell lymphoma
The platform revolutionizes how providers deliver financial services by radically simplifying the patient financial experience
Over 70 per cent of the world’s population have no access to MRI scanners and the situation is not that encouraging in India where there are only 0.4 MRI scanners per thousand people
The company plans to enter the formulation business in January 2022. It has also opened a branch in Hyderabad to trade pharmaceutical chemicals
HTL will build, validate and operate a botulinum manufacturing facility in the US
Subscribe To Our Newsletter & Stay Updated
